IFNB1 and COVID-19: In addition, WHO launched the initiative SOLIDARITY, aimed at monitoring COVID-19 patients globally, randomized to local standard care or one of the four drug regimens: antiviral drug remdesivir, the malaria medication chloroquine or hydroxychloroquine, a combination of HIV drugs lopinavir and ritonavir, and that combination plus interferon-beta [64].